Influence of Bio-Oss Collagen Grafting at Implant Placement on Buccal Bone Volume Regeneration
NCT ID: NCT04338139
Last Updated: 2020-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-01-01
2021-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Pre-operatively:
* cone beam computed tomography CBCT
* 1 minute mouthwash with a 0.12% Chlorhexidine solution
* Full thickness muco-periosteal flap and ridge curettage.
* Drilling and implant placement (any implant system)
* Adjustment and placement of the "Bio-Oss Collagen" in the regeneration site without a fixation membrane.
* Hermetic wound closure with U-shaped and simple stitches using 5/0 and 6/0 PGA resorbable material.
* Post-operatively:
* Medication:
* Amoxicilline (1g) or Clindamycine (300mg)
* Analgesic, (paracetamol + codeine)
* Mouthwash with a solution of 0.12% Chlorhexidine
* cone beam computed tomography CBCT
* 4 months postoperatively: CBCT
Bio-oss collagen is placed on the buccal side after implant placement and adapted to have the bone defect morphology. the full thickness flap is then closed without membrane placement and the bone bock is fixed in place through sutures only. CBCT images were taken immediately postoperatively and at 4 months after bone grafting. Imaging superposition (on ITK software) and measurements of buccal bone gain were effectuated to evaluate the efficiency of this regeneration technique. evaluation of buccal bone regeneration through linear radiographic measurements and evaluation of the % of grafted bone resorption will indicate the success of this technique
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lateral Ridge Augmentation Using Cross-linked or Non-cross-linked Collagen Membrane
NCT04402671
Hyaluronic Acid Effect on Xenogenic Bone Healing
NCT04377256
Radiographic Evaluation of The Labial Bone Dimensional Changes After Immediate Implant
NCT05360693
Bone Remodeling After Immediate Implant Placement With and Without Bone Grafting
NCT02174198
Alveolar Ridge Preservation With Layered Collagen and Xenograft
NCT05683509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bio-oss Collagen
90% xengeneic bovine bone partciles + 10% collagen type I
bone regeneration
bone regeneration using bio-oss collagen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bone regeneration
bone regeneration using bio-oss collagen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smoking \<10 cigarettes/day (Light smoker)
* Good general health.
* Absence of acute infection: edema, suppuration, abscess, spontaneous bleeding.
Exclusion Criteria
* Pathologies that may impair bone healing: diabetes, autoimmune diseases, corticosteroids, chemotherapy.
Orthodontic treatment in progress or planned
\- Adjacent risk teeth
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint-Joseph University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint-Joseph University
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USJ-2019-112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.